AbbVie spends $100B on R and D, buys Regeneron for $5.6B to bolster pipeline amidst US pharma pricing shifts

Tuesday, Jan 13, 2026 7:52 am ETnullmin read

Comments



Add a public comment...
No comments

No comments yet